April 11, 2017 / 6:37 AM / 3 months ago

BRIEF-Isofol successfully comples ISO-MTX-003 study with Modufolin

1 Min Read

April 11 (Reuters) - ISOFOL MEDICAL AB:

* ISOFOL HAS SUCCESSFULLY COMPLETED THE ISO-MTX-003 STUDY IN WHICH MODUFOLIN IS EVALUATED AS RESCUE THERAPY

* STUDY SUCCESSFULLY MET RECRUITMENT GOALS OF PHASE I/II OPEN-LABEL, MULTICENTER CLINICAL TRIAL

* SAYS WILL CONTINUE TO PURSUE DEVELOPMENT OF MODUFOLIN AS A RESCUE AGENT FOR OSTEOSARCOMA PATIENTS FOLLOWING HDMTX-TREATMENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below